About: http://hub.abes.fr/oup/periodical/annonc/2004/volume_15/issue_2/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/oup/periodical/annonc/2004/volume_15/issue_2/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/annonc/2004/volume_15
has manifestation of work	http://hub.abes.fr/oup/periodical/annonc/2004/volume_15/issue_2/m/print http://hub.abes.fr/oup/periodical/annonc/2004/volume_15/issue_2/m/web
Date Copyrighted	2004
Rights	European Society for Medical Oncology
issue	2
is Is Part Of of	Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy Successful treatment of AIDS-related Castleman’s disease following the administration of highly active antiretroviral therapy (HAART) Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean) Chemoprevention of lung cancer—from biology to clinical reality Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients Evaluation of renal function in elderly cancer patients Modified RECIST criteria for assessment of response in malignant pleural mesothelioma Chemoradiation in Cancer Therapy European Society of Medical Oncology membership survey Processed meat and the risk of selected digestive tract and laryngeal neoplasms in Switzerland Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer First-line hepatic infusion of pirarubicin in patients with isolated liver metastases: is it really promising? The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, ‘Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients’ Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results Factors influencing treatment recommendations in early-stage Hodgkin’s disease: a survey of physicians Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin’s disease Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study Monitoring falls in gastric cancer mortality in Europe Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study Evidence-based Oncology Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG) Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial Postoperative chemoradiotherapy after curative gastrectomy for cancer

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata